Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001178913-25-000679
Filing Date
2025-03-04
Accepted
2025-03-04 07:30:38
Documents
89
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 20-F zk2532769.htm   iXBRL 20-F 2540395
2 EXHIBIT 2.1 exhibit_2-1.htm EX-2.1 38846
3 EXHIBIT 8.1 exhibit_8-1.htm EX-8.1 2142
4 EXHIBIT 11.B exhibit_11-b.htm EX-11 65544
5 EXHIBIT 12-1 exhibit_12-1.htm EX-12.1 9020
6 EXHIBIT 12.2 exhibit_12-2.htm EX-12.2 8105
7 EXHIBIT 13.1 exhibit_13-1.htm EX-13.1 4104
8 EXHIBIT 15.1 exhibit_15-1.htm EX-15.1 4247
14 GRAPHIC image0.jpg GRAPHIC 422262
  Complete submission text file 0001178913-25-000679.txt   10656011

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE cgen-20241231.xsd EX-101.SCH 63768
10 XBRL CALCULATION FILE cgen-20241231_cal.xml EX-101.CAL 50682
11 XBRL DEFINITION FILE cgen-20241231_def.xml EX-101.DEF 197152
12 XBRL LABEL FILE cgen-20241231_lab.xml EX-101.LAB 675111
13 XBRL PRESENTATION FILE cgen-20241231_pre.xml EX-101.PRE 346816
91 EXTRACTED XBRL INSTANCE DOCUMENT zk2532769_htm.xml XML 1582716
Mailing Address 26 HAROKMIM STREET BUILDING D HOLON L3 5885849
Business Address 26 HAROKMIM STREET BUILDING D HOLON L3 5885849 011-972-3-765-8585
COMPUGEN LTD (Filer) CIK: 0001119774 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 000-30902 | Film No.: 25701560
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)